Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot Study

Background: : Exacerbations of bronchial asthma usually occur in the autumn. To our knowledge, however, the effectiveness of drugs for preventing exacerbations of asthma in the autumn has not been studied previously, except for leukotriene receptor antagonists and Omalizmab. Methods: : This study co...

Full description

Bibliographic Details
Main Authors: Shigemi Yoshihara, Yumi Yamada, Hironobu Fukuda, Takayoshi Tsuchiya, Mika Ono, Norimasa Fukuda, Noriko Kanno, Osamu Arisaka
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893015300320
_version_ 1818482923475566592
author Shigemi Yoshihara
Yumi Yamada
Hironobu Fukuda
Takayoshi Tsuchiya
Mika Ono
Norimasa Fukuda
Noriko Kanno
Osamu Arisaka
author_facet Shigemi Yoshihara
Yumi Yamada
Hironobu Fukuda
Takayoshi Tsuchiya
Mika Ono
Norimasa Fukuda
Noriko Kanno
Osamu Arisaka
author_sort Shigemi Yoshihara
collection DOAJ
description Background: : Exacerbations of bronchial asthma usually occur in the autumn. To our knowledge, however, the effectiveness of drugs for preventing exacerbations of asthma in the autumn has not been studied previously, except for leukotriene receptor antagonists and Omalizmab. Methods: : This study compared the prophylactic effectiveness of suplatast tosilate with that of mequitazine in children with asthma symptoms, which is usually exacerbated in the autumn. The study group comprised 27 children aged 2 to 15 years who required treatment for asthmatic attacks during the past year and tested positive at least for mite allergen in the preceding autumn. The subjects were randomly assigned to receive either suplatast or mequitazine. The primary endpoint of this study was the number of days without symptoms during the 8 weeks of treatment. In addition, the Japanese Pediatric Asthma Control Program (JPAC) scores were also recorded every 2 weeks in each group. Results: : Overall, 14 patients received suplatast, and 13 received mequitazine for 8 weeks from September through early October. During follow-up, the number of days without symptoms and the total JPAC scores did not differ significantly between the groups. However, as compared with weeks 1 to 2 of treatment, the mean number of days without symptoms during weeks 7 to 8 increased significantly in only the suplatast group (8.6 vs. 11.5 days; p = 0.004). Conclusions: : Our results suggest that short-term additional treatment with suplatast is useful for preventing asthma symptoms in children with asthma, which is usually exacerbated in the autumn.
first_indexed 2024-12-10T11:53:21Z
format Article
id doaj.art-0578f0a9a2a249ca98f90ce48295199d
institution Directory Open Access Journal
issn 1323-8930
language English
last_indexed 2024-12-10T11:53:21Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Allergology International
spelling doaj.art-0578f0a9a2a249ca98f90ce48295199d2022-12-22T01:49:51ZengElsevierAllergology International1323-89302014-01-0163219920310.2332/allergolint.13-OA-0583Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot StudyShigemi Yoshihara0Yumi Yamada1Hironobu Fukuda2Takayoshi Tsuchiya3Mika Ono4Norimasa Fukuda5Noriko Kanno6Osamu Arisaka7Department of Pediatrics, Dokkyo Medical UniversityTsuchiya Children’s Hospital, Saitama, Japan.Department of Pediatrics, Dokkyo Medical UniversityTsuchiya Children’s Hospital, Saitama, Japan.Nogi HospitalGrimm Pediatric and Allergy ClinicNishikata Hospital, TochigiDepartment of Pediatrics, Dokkyo Medical UniversityBackground: : Exacerbations of bronchial asthma usually occur in the autumn. To our knowledge, however, the effectiveness of drugs for preventing exacerbations of asthma in the autumn has not been studied previously, except for leukotriene receptor antagonists and Omalizmab. Methods: : This study compared the prophylactic effectiveness of suplatast tosilate with that of mequitazine in children with asthma symptoms, which is usually exacerbated in the autumn. The study group comprised 27 children aged 2 to 15 years who required treatment for asthmatic attacks during the past year and tested positive at least for mite allergen in the preceding autumn. The subjects were randomly assigned to receive either suplatast or mequitazine. The primary endpoint of this study was the number of days without symptoms during the 8 weeks of treatment. In addition, the Japanese Pediatric Asthma Control Program (JPAC) scores were also recorded every 2 weeks in each group. Results: : Overall, 14 patients received suplatast, and 13 received mequitazine for 8 weeks from September through early October. During follow-up, the number of days without symptoms and the total JPAC scores did not differ significantly between the groups. However, as compared with weeks 1 to 2 of treatment, the mean number of days without symptoms during weeks 7 to 8 increased significantly in only the suplatast group (8.6 vs. 11.5 days; p = 0.004). Conclusions: : Our results suggest that short-term additional treatment with suplatast is useful for preventing asthma symptoms in children with asthma, which is usually exacerbated in the autumn.http://www.sciencedirect.com/science/article/pii/S1323893015300320asthmapediatricsseasonalsuplatast tosilateTh2 cytokines
spellingShingle Shigemi Yoshihara
Yumi Yamada
Hironobu Fukuda
Takayoshi Tsuchiya
Mika Ono
Norimasa Fukuda
Noriko Kanno
Osamu Arisaka
Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot Study
Allergology International
asthma
pediatrics
seasonal
suplatast tosilate
Th2 cytokines
title Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot Study
title_full Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot Study
title_fullStr Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot Study
title_full_unstemmed Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot Study
title_short Prophylactic Effectiveness of Suplatast Tosilate in Children with Asthma Symptoms in the Autumn: A Pilot Study
title_sort prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn a pilot study
topic asthma
pediatrics
seasonal
suplatast tosilate
Th2 cytokines
url http://www.sciencedirect.com/science/article/pii/S1323893015300320
work_keys_str_mv AT shigemiyoshihara prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy
AT yumiyamada prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy
AT hironobufukuda prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy
AT takayoshitsuchiya prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy
AT mikaono prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy
AT norimasafukuda prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy
AT norikokanno prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy
AT osamuarisaka prophylacticeffectivenessofsuplatasttosilateinchildrenwithasthmasymptomsintheautumnapilotstudy